Using a murine TAC-induced pressure overload HF model, we then determined whether NMEG-CGRP administration every other day for 28 days, starting two days post-TAC, prevented the development of cardiac dysfunction and remodeling (termed prevention study) [38]. This evidence concerns the gene CALCA and persistent truncus arteriosus.